Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.71 |
| ▸ | MEN1 | O00255 | 4/20 | 0.71 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.71 |
| ▸ | TACR1 | P25103 | 5/20 | 0.71 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | TP53 | P04637 | 2/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.66 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.66 |
| ▸ | APEX1 | P27695 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | THPO | P40225 | 1/20 | 0.66 |
| ▸ | BLM | P54132 | 1/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL468840 | 1.00 | KMT2A (0.71) | KMT2AMEN1HCRTR1TACR1MAPT | |
| SCHEMBL3184939 | 1.00 | KMT2A (0.71) | KMT2AMEN1HCRTR1TACR1MAPT | |
| SCHEMBL29138492 | 0.90 | TACR1 (0.63) | KMT2AMEN1HCRTR1TACR1MAPT | |
| SCHEMBL16626132 | 0.90 | TACR1 (0.63) | KMT2AMEN1HCRTR1TACR1MAPT | |
| SCHEMBL6362124 | 0.90 | TACR1 (0.63) | KMT2AMEN1HCRTR1TACR1MAPT | |
| SCHEMBL6355051 | 0.90 | TACR1 (0.63) | KMT2AMEN1HCRTR1TACR1MAPT | |
| SCHEMBL850315 | 0.90 | TACR1 (0.74) | KMT2AMEN1HCRTR1TACR1MAPT | |
| SCHEMBL3185689 | 0.90 | TACR1 (0.74) | KMT2AMEN1HCRTR1TACR1MAPT | |
| SCHEMBL5385762 | 0.90 | TACR1 (0.72) | KMT2AMEN1HCRTR1TACR1MAPT | |
| SCHEMBL30359404 | 0.90 | TACR1 (0.72) | KMT2AMEN1HCRTR1TACR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4345104-B1 | METHOD FOR PREPARING LIRAGLUTIDE | BACHEM HOLDING AG (CH) | 2024-08-28 | — | — | EP | claimed |
| US-12577274-B2 | Manufacture of glucagon peptides | BACHEM HOLDING AG (CH) | 2026-03-17 | — | — | US | disclosed |
| WO-2025229200-A1 | MANUFACTURE OF DISULFIDE BONDED PEPTIDES | BACHEM HOLDING AG (CH) | 2025-11-06 | — | — | WO | disclosed |
| EP-3728304-B1 | SOLID PHASE SYNTHESIS OF ACYLATED PEPTIDES | BACHEM HOLDING AG (CH) | 2025-02-12 | — | — | EP | disclosed |
| US-20240316223-A1 | Oxidative Cyclization Reagents for Chemoselective Tryptophan Bioconjugation | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-09-26 | — | — | US | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| CN-118515597-A | Visible light mediated tryptophan indole C-2 site selective arylation modification method and application thereof | 中国科学院深圳先进技术研究院 | 2024-08-20 | — | — | CN | disclosed |
| WO-2024081692-A1 | MITHRAMYCIN OXIME DERIVATIVES HAVING INCREASED SELECTIVITY AND ANTI-CANCER ACTIVITY | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2024-04-18 | — | — | WO | disclosed |
| CN-111670194-B | Preparation of glucagon peptides | 巴赫姆控股股份公司 | 2024-01-26 | — | — | CN | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| CN-116829949-A | Compositions for detecting or measuring analytes | 伯蒂斯有限公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2023114615-A1 | OXIDATIVE CYCLIZATION REAGENTS FOR CHEMOSELECTIVE TRYPTOPHAN BIOCONJUGATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| EP-3746466-B1 | MANUFACTURE OF GLUCAGON PEPTIDES | BACHEM AG (CH) | 2022-11-23 | — | — | EP | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| EP-3433267-B1 | METHOD FOR PREPARING GLUCAGON-LIKE PEPTIDES | BACHEM HOLDING AG (CH) | 2022-08-24 | — | — | EP | disclosed |
| US-20220259258-A1 | A Manufacturing Process for Peptide and Protein Production | MYTIDE THERAPEUTICS, INC. | 2022-08-18 | — | — | US | disclosed |
| EP-3983424-A1 | A MANUFACTURING PROCESS FOR PEPTIDE AND PROTEIN PRODUCTION | Mytide Therapeutics, Inc. (US) | 2022-04-20 | — | — | EP | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577274-B2 | Manufacture of glucagon peptides | IAPP, GLP1R, GCG | KMT2A 4018/4885MEN1 957/4885HCRTR1 2791/4885 |
| US-20240316223-A1 | Oxidative Cyclization Reagents for Chemoselective Tryptophan Bioconjugation | TDO2, TPH1, TPH2 | KMT2A 2305/4885MEN1 3689/4885HCRTR1 163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.